127 related articles for article (PubMed ID: 37863326)
21. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
[TBL] [Abstract][Full Text] [Related]
22. Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti-Acute Myeloid Leukemia Efficacy In Vitro and In Vivo.
Cao ZX; Wen Y; He JL; Huang SZ; Gao F; Guo CJ; Liu QQ; Zheng SW; Gong DY; Li YZ; Zhang RQ; Chen JP; Peng C
Mol Pharmacol; 2019 Nov; 96(5):589-599. PubMed ID: 31462456
[TBL] [Abstract][Full Text] [Related]
23. ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Downregulation of PI3K/AKT/mTOR Pathway in vivo and in vitro.
Song L; Luo Y; Li S; Hong M; Wang Q; Chi X; Yang C
Drug Des Devel Ther; 2020; 14():4363-4376. PubMed ID: 33116421
[TBL] [Abstract][Full Text] [Related]
24. Histone variant H2A.Z.2: A novel driver of melanoma progression.
Vardabasso C; Hake SB; Bernstein E
Mol Cell Oncol; 2016 Mar; 3(2):e1073417. PubMed ID: 27308593
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent.
Huang F; Wang J; Xu Y; Zhang Y; Xu N; Yin L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515470
[TBL] [Abstract][Full Text] [Related]
26. H2A.Z overexpression suppresses senescence and chemosensitivity in pancreatic ductal adenocarcinoma.
Ávila-López PA; Guerrero G; Nuñez-Martínez HN; Peralta-Alvarez CA; Hernández-Montes G; Álvarez-Hilario LG; Herrera-Goepfert R; Albores-Saavedra J; Villegas-Sepúlveda N; Cedillo-Barrón L; Montes-Gómez AE; Vargas M; Schnoor M; Recillas-Targa F; Hernández-Rivas R
Oncogene; 2021 Mar; 40(11):2065-2080. PubMed ID: 33627784
[TBL] [Abstract][Full Text] [Related]
27. Anti-proliferative and cytotoxic activities of the flavonoid isoliquiritigenin in the human neuroblastoma cell line SH-SY5Y.
Escobar SJM; Fong GM; Winnischofer SMB; Simone M; Munoz L; Dennis JM; Rocha MEM; Witting PK
Chem Biol Interact; 2019 Feb; 299():77-87. PubMed ID: 30502331
[TBL] [Abstract][Full Text] [Related]
28. Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.
Chen C; Shenoy AK; Padia R; Fang D; Jing Q; Yang P; Su SB; Huang S
J Exp Clin Cancer Res; 2018 Oct; 37(1):243. PubMed ID: 30285892
[TBL] [Abstract][Full Text] [Related]
29. Molecular signatures in response to Isoliquiritigenin in lymphoblastoid cell lines.
Lee JE; Hong EJ; Nam HY; Hwang M; Kim JH; Han BG; Jeon JP
Biochem Biophys Res Commun; 2012 Oct; 427(2):392-7. PubMed ID: 22995316
[TBL] [Abstract][Full Text] [Related]
30. Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin.
Lee YM; Lim DY; Choi HJ; Jung JI; Chung WY; Park JH
J Med Food; 2009 Feb; 12(1):8-14. PubMed ID: 19298190
[TBL] [Abstract][Full Text] [Related]
31. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer.
Wang G; Yu Y; Wang YZ; Yin PH; Xu K; Zhang H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1231-1249. PubMed ID: 32985258
[TBL] [Abstract][Full Text] [Related]
32. Isoliquiritigenin-induced differentiation in mouse melanoma B16F0 cell line.
Chen X; Zhang B; Yuan X; Yang F; Liu J; Zhao H; Liu L; Wang Y; Wang Z; Zheng Q
Oxid Med Cell Longev; 2012; 2012():534934. PubMed ID: 23304254
[TBL] [Abstract][Full Text] [Related]
33. Isoliquiritigenin suppresses tumor necrosis factor-α-induced inflammation via peroxisome proliferator-activated receptor-γ in intestinal epithelial cells.
Jin XY; Sohn DH; Lee SH
Arch Pharm Res; 2016 Oct; 39(10):1465-1471. PubMed ID: 27539609
[TBL] [Abstract][Full Text] [Related]
34. The effects of isoliquiritigenin on endometriosis in vivo and in vitro study.
Hsu YW; Chen HY; Chiang YF; Chang LC; Lin PH; Hsia SM
Phytomedicine; 2020 Oct; 77():153214. PubMed ID: 32736296
[TBL] [Abstract][Full Text] [Related]
35. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
[TBL] [Abstract][Full Text] [Related]
36. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.
Dar AA; Majid S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M
J Biol Chem; 2011 May; 286(19):16606-14. PubMed ID: 21454583
[TBL] [Abstract][Full Text] [Related]
37. Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth.
Chen HY; Huang TC; Shieh TM; Wu CH; Lin LC; Hsia SM
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934130
[TBL] [Abstract][Full Text] [Related]
38. Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention.
Sun X; Zhang J; Wang Z; Liu B; Zhu S; Zhu L; Peng B
Theranostics; 2019; 9(18):5183-5199. PubMed ID: 31410209
[TBL] [Abstract][Full Text] [Related]
39. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway.
Zhang XR; Wang SY; Sun W; Wei C
Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879
[TBL] [Abstract][Full Text] [Related]
40. Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases.
Chen Z; Ding W; Yang X; Lu T; Liu Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):117059. PubMed ID: 37604329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
